We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

High magnification micrograph of microglia cells stained with Rio-Hortega's method (silver carbonate). This type is the ramified or resting microglia that appears in normal brain tissue.

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

A scientist in a lab holding up a centrifuge tube.

Materials Follow the “Rule of Four” — But Scientists Don’t Know Why Yet

A microscope sits in the middle of sets of wires.

Nerve Cells in the Human Neocortex Are Wired Differently Than in Mice

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Neuro-Cognitive Computer Models Make Reading More Efficient

Promising Treatment Approach for Aggressive Leukemia Identified

News

CAL FluorR Patent Issued to Biosearch Technologies

Company has been awarded U.S. Patent describing the CAL Fluor® series of fluorescent dyes for modifying synthetic DNA to enhance its detectability.

Amorcyte Completes Phase I Trial of Stem Cell Therapy for Acute Myocardial Infarction

Amorcyte lead product, AMR-001, is an autologous stem cell product for the treatment of damaged heart muscle following AMI.

PerkinElmer Expands its OneSource® Laboratory Services with Acquisition of LabMetrix Technologies

The acquisition adds technology, tools, proven processes and compliance expertise to PerkinElmer’s suite of OneSource® laboratory services.

Cell Genesys and Takeda Announce Global Development and Commercialization Alliance

The agreement aims at developing and commercializing Cell Genesys' GVAX immunotherapy for prostate cancer.

NeoPharm Enrolls First Patients in Phase II Metastatic Breast Cancer Study

Company has enrolled its first patients in its multi-center open-label, Phase II clinical trial for efficacy and safety of Liposomal Paclitaxel.

Laureate Announces Second Manufacturing Agreement with Cytheris

Laureate to manufacture Cytheris' lead product candidate, interleukin-7, currently in clinical trials for treatment of HIV, HCV and cancer.

Acusphere Licenses Hydrophobic Drug Delivery System to Cephalon for $10 Million

Acusphere signs agreement to license the intellectual property rights to its HDDS for oncology applications to Cephalon.

UNIchip protein biochips from Protagen identify significant off-target binding for TNF-alpha inhibitors

Tumor Necrosis Factor-a inhibitors used to treat rheumatic diseases may bind to a significant number of proteins other than their main target, according to the results of an in vitro study published in Analytical and Bioanalytical Chemistry.

Integromics´ Real-Time StatMiner Chosen by Genzyme Corp. for Use In qPCR Analysis

Integromics has announced that Genzyme Corporation has licensed Real-Time StatMiner for their nucleic acids analysis.

Seattle Genetics Expands SGN-35 Clinical Program with Initiation of Second Phase I Trial

SGN-35 is an antibody-drug conjugate that utilizes company’s technology to empower antibodies by linking them to potent cell-killing drugs.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter